RevOpsis Awarded $1.8M Grant To Advance Ophthalmic Therapies
15 Oct 2024 //
PR NEWSWIRE
RevOpsis and Kemwell partner to boost biologic development
18 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
RevOpsis And Kemwell Enter Partnership For Novel Biologics Development
17 Jun 2024 //
PR NEWSWIRE